The healthcare industry is pressured to lower spending while increasing quality of care, though costly inequities in the system are only expected to rise over the next few decades, according to the new research from Deloitte.
Researchers looked at high-cost diseases like breast cancer, diabetes, colorectal cancer, asthma and cardiovascular disease to determine how much spending was due to inequities, which can often be attributed to late diagnoses and comorbidities that impact patient outcomes, according to the report.
